Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Grating-based x-ray phase-contrast imaging with a multi energy-channel photon-counting pixel detector.
Pelzer G, Weber T, Anton G, Ballabriga R, Bayer F, Campbell M, Gabor T, Haas W, Horn F, Llopart X, Michel N, Mollenbauer U, Rieger J, Ritter A, Ritter I, Sievers P, Wölfel S, Wong WS, Zang A, Michel T. Pelzer G, et al. Among authors: zang a. Opt Express. 2013 Nov 4;21(22):25677-84. doi: 10.1364/OE.21.025677. Opt Express. 2013. PMID: 24216793 Free article.
Energy weighted x-ray dark-field imaging.
Pelzer G, Zang A, Anton G, Bayer F, Horn F, Kraus M, Rieger J, Ritter A, Wandner J, Weber T, Fauler A, Fiederle M, Wong WS, Campbell M, Meiser J, Meyer P, Mohr J, Michel T. Pelzer G, et al. Among authors: zang a. Opt Express. 2014 Oct 6;22(20):24507-15. doi: 10.1364/OE.22.024507. Opt Express. 2014. PMID: 25322026 Free article.
On a dark-field signal generated by micrometer-sized calcifications in phase-contrast mammography.
Michel T, Rieger J, Anton G, Bayer F, Beckmann MW, Durst J, Fasching PA, Haas W, Hartmann A, Pelzer G, Radicke M, Rauh C, Ritter A, Sievers P, Schulz-Wendtland R, Uder M, Wachter DL, Weber T, Wenkel E, Zang A. Michel T, et al. Among authors: zang a. Phys Med Biol. 2013 Apr 21;58(8):2713-32. doi: 10.1088/0031-9155/58/8/2713. Epub 2013 Apr 3. Phys Med Biol. 2013. PMID: 23552903
Long-term follow-up of zimberelimab in relapsed or refractory classic Hodgkin lymphoma: Insights from the phase Ⅱ YH-S001-04 clinical trial.
Kan S, Bai H, Liu H, Cui J, Ke X, Zhang H, Liu L, Yan D, Jiang Y, Zang A, Qi J, Wang L, Liu Z, Xu B, Zhang Y, Zhang Z, Zhao X, Hu C, Yang S, Zhou H, Shi J, Shao Z, Xiang Y, Lin N, Zhang M. Kan S, et al. Among authors: zang a. Leuk Res. 2024 Nov 26;149:107633. doi: 10.1016/j.leukres.2024.107633. Online ahead of print. Leuk Res. 2024. PMID: 39799811
A plain language summary of results from the TORCHLIGHT trial of toripalimab plus chemotherapy for metastatic or recurrent triple-negative breast cancer.
Jiang Z, Ouyang Q, Sun T, Zhang Q, Teng Y, Cui J, Wang H, Yin Y, Wang X, Zhou X, Wang Y, Sun G, Wang J, Zhang L, Yang J, Qian J, Yan M, Liu X, Yi T, Cheng Y, Li M, Zang A, Wang S, Wang C, Wu X, Cheng J, Li H, Lin Y, Geng C, Gu K, Xie C, Xiong H, Wu X, Yang J, Li Q, Chen Y, Li F, Zhang A, Zhang Y, Wu Y, Nie J, Liu Q, Wang K, Mo X, Chen L, Pan Y, Fu P, Zhang H, Pang D, Sheng Y, Han Y, Wang H, Cang S, Luo X, Yu W, Deng R, Yang C, Keegan P. Jiang Z, et al. Among authors: zang a. Future Oncol. 2024 Dec 4:1-9. doi: 10.1080/14796694.2024.2430106. Online ahead of print. Future Oncol. 2024. PMID: 39628303 Free article.
Randomized, Phase III Trial of Mixed Formulation of Fosrolapitant and Palonosetron (HR20013) in Preventing Cisplatin-Based Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: PROFIT.
Zhou H, Zhao Y, Zhang M, Yao J, Leng S, Li X, Lin L, Chen J, Zhang S, Qin X, Qin Z, Yi T, Wang R, Li X, Yu Y, Wang Z, Zheng Q, Mei J, Zang A, Li N, Cao F, Cao K, Li W, Lu Y, Lin D, Zhou Y, Yang R, Fang W, Zhou N, Yang Y, Zhang Y, Chen G, Zhou T, Yang X, Wang H, Wang Y, Huang Y, Zhang L. Zhou H, et al. Among authors: zang a. J Clin Oncol. 2024 Dec 2:JCO2401308. doi: 10.1200/JCO-24-01308. Online ahead of print. J Clin Oncol. 2024. PMID: 39621965
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer.
Bardia A, Hu X, Dent R, Yonemori K, Barrios CH, O'Shaughnessy JA, Wildiers H, Pierga JY, Zhang Q, Saura C, Biganzoli L, Sohn J, Im SA, Lévy C, Jacot W, Begbie N, Ke J, Patel G, Curigliano G; DESTINY-Breast06 Trial Investigators. Bardia A, et al. N Engl J Med. 2024 Dec 5;391(22):2110-2122. doi: 10.1056/NEJMoa2407086. Epub 2024 Sep 15. N Engl J Med. 2024. PMID: 39282896 Clinical Trial.
125 results